WAM
VNRX icon

Warberg Asset Management’s VolitionRx Ltd VNRX Stock Holding History

Warberg Asset Management’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,542
Closed -$23.2K – 213
2025
Q4 		$23.2K Buy
+4,542
New +$34.5K ﹤0.01% 157

Other funds holding VNRX

LIM
Lagoda Investment Management New York $182M AUM 58.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return

Warberg Asset Management's VNRX Position: Q1 2026 in Review

Warberg Asset Management sold out of VolitionRx Ltd (VNRX) in Q1 2026, closing a stake of 4,542 shares — an estimated $23.2K sold.

Warberg Asset Management first reported a position in VNRX in Q4 2025 and held it in 1 quarter. The position peaked at $23.2K in Q4 2025. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • Warberg Asset Management reported no remaining VolitionRx Ltd position as of Q1 2026 after selling out during the quarter.
  • Warberg Asset Management sold 4,542 VolitionRx Ltd shares in Q1 2026, an estimated $23.2K.
  • Warberg Asset Management first reported a position in VolitionRx Ltd in Q4 2025 and held it in 1 quarter.
  • Warberg Asset Management's VolitionRx Ltd position peaked at $23.2K in Q4 2025.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Warberg Asset Management's 13F filing for Q1 2026, filed 7 May 2026.